Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Anticholinergic Syndrome
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Anticholinergic Syndrome
Tree Number(s)
C25.100.311
Unique ID
D064807
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D064807
Scope Note
Adverse drug effects associated with
CHOLINERGIC ANTAGONISTS
. Clinical features include
TACHYCARDIA
;
HYPERTHERMIA
;
MYDRIASIS
, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and
HALLUCINATIONS
;
PSYCHOSES
;
SEIZURES
; and
COMA
in central anticholinergic syndrome.
Entry Term(s)
Central Anticholinergic Syndrome
Peripheral Anticholinergic Syndrome
Previous Indexing
Cholinergic Antagonists (1995-2013)
See Also
Cholinergic Antagonists
Public MeSH Note
2014
History Note
2014
Date Established
2014/01/01
Date of Entry
2013/07/08
Revision Date
1955/01/01
Allowable Qualifiers
blood (BL)
cerebrospinal fluid (CF)
classification (CL)
complications (CO)
congenital (CN)
diagnosis (DI)
diagnostic imaging (DG)
diet therapy (DH)
drug therapy (DT)
economics (EC)
embryology (EM)
enzymology (EN)
epidemiology (EP)
ethnology (EH)
etiology (ET)
genetics (GE)
history (HI)
immunology (IM)
metabolism (ME)
microbiology (MI)
mortality (MO)
nursing (NU)
parasitology (PS)
pathology (PA)
physiopathology (PP)
prevention & control (PC)
psychology (PX)
radiotherapy (RT)
rehabilitation (RH)
surgery (SU)
therapy (TH)
urine (UR)
veterinary (VE)
virology (VI)
Chemically-Induced Disorders [C25]
Drug-Related Side Effects and Adverse Reactions [C25.100]
Akathisia, Drug-Induced [C25.100.249]
Anticholinergic Syndrome [C25.100.311]
Cardiotoxicity [C25.100.389]
Chemotherapy-Related Cognitive Impairment [C25.100.429]
Drug Hypersensitivity [C25.100.468]
Chemical and Drug Induced Liver Injury [C25.100.562]
Ototoxicity [C25.100.656]
Dyskinesia, Drug-Induced [C25.100.750]
Injection Site Reaction [C25.100.781]
Metabolic Side Effects of Drugs and Substances [C25.100.812]
Myotoxicity [C25.100.828]
Propofol Infusion Syndrome [C25.100.844]
Serotonin Syndrome [C25.100.875]
Toxic Optic Neuropathy [C25.100.937]
Expand All
Collapse All
Anticholinergic Syndrome
Preferred
Concept UI
M0584238
Scope Note
Adverse drug effects associated with
CHOLINERGIC ANTAGONISTS
. Clinical features include
TACHYCARDIA
;
HYPERTHERMIA
;
MYDRIASIS
, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and
HALLUCINATIONS
;
PSYCHOSES
;
SEIZURES
; and
COMA
in central anticholinergic syndrome.
Terms
Anticholinergic Syndrome
Preferred Term
Term UI
T843046
Date
04/26/2013
LexicalTag
NON
ThesaurusID
NLM (2014)
Central Anticholinergic Syndrome
Narrower
Concept UI
M0584239
Terms
Central Anticholinergic Syndrome
Preferred Term
Term UI
T843047
Date
04/26/2013
LexicalTag
NON
ThesaurusID
NLM (2014)
Peripheral Anticholinergic Syndrome
Narrower
Concept UI
M0584240
Terms
Peripheral Anticholinergic Syndrome
Preferred Term
Term UI
T843188
Date
04/26/2013
LexicalTag
NON
ThesaurusID
NLM (2014)
page delivered in 0.151s